Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV-supported projects
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Product availability maps
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Tool Kits
Injectable Artesunate tool kit
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Socially responsible agreements
Our clinical centre partners
Our impact
Milestones
Real life stories
Better medicines for children
Gender equity
Global health security
Malaria and COVID-19
Tackling antimicrobial resistance
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
Five species
Parasite lifecycle
Malaria facts & figures
Malaria treatment
History of antimalarials
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
Malaria
Libre
About Malaria
Libre
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
News & Press Releases
News & Press Releases
Filter
Category
All
News story
Press release
Topic
Access & product management
Donors
General
Open source
Partner
R&D
Search Terms
456 found
The power of partnership
16 Apr 2009
MMV and Merck & Co. to develop promising antimalarial compound
18 Mar 2009
MMV in the News: Economist Intelligence Unit: World diseases: Can the private sector cure malaria?
24 Feb 2009
MMV and Novartis launch Coartem®
Dispersible
20 Feb 2009
MMV and Novartis launch Coartem®
Dispersible
in Africa
15 Feb 2009
MMV in the News: Economist Intelligence Unit: ACTs on a Roll
13 Feb 2009
Unique collaboration launches a new malaria medicine to save millions of children
27 Jan 2009
MMV to collaborate with GSK on development of Tafenoquine for P.Vivax malaria
15 Dec 2008
StopMalariaNow! Calls upon European governments to prioritise malaria control
26 Nov 2008
New technologies gearing up to meet rising demand for antimalarials
19 Nov 2008
Nature Reviews Drug Discovery: Interview with MMV CSO Tim Wells
11 Nov 2008
MMV applauds GFATM’s decision to host AMFm
11 Nov 2008
First-ever comprehensive report on the antimalarials market in Uganda shows how understanding markets can help improve access to medicines
05 Nov 2008
MMV signs MOU with sanofi-aventis
22 Oct 2008
MMV welcomes the prequalification of ASAQ
20 Oct 2008
Baroness Chalker of Wallasey addresses House of Lords on MDGs
07 Oct 2008
Bill & Melinda Gates Foundation: Bill Gates addresses UN General Assembly
25 Sep 2008
Unforgettable launch of MMV-MOH Uganda pilot
22 Sep 2008
Genzyme Corporation and MMV Announce New Collaboration with Advinus Therapeutics to Accelerate Discovery of Novel Therapies for Malaria
26 Aug 2008
World Bank Global Program Review (GPR) is published
15 Aug 2008
Spain becomes a major government funder of MMV
31 May 2008
First World Malaria Day
25 Apr 2008
MMV and other PDPs co-sign position paper on key issues raised in IGWG
23 Apr 2008
MMV welcomes the drop in price of life-saving Coartem®
23 Apr 2008
Report published on ‘Methods and Techniques for Clinical Trials on Antimalarial Drug Efficacy’
03 Apr 2008
MMV co-sponsor of RBM Partnership’s Zambezi Expedition
28 Mar 2008
Position paper and presentations: Exploring combinations of antimalarial drugs meeting
19 Mar 2008
Dacart development halted based on Phase III results
29 Feb 2008
MMV and other PPPs encourage additional US Government support
11 Jan 2008
MMV features in The Pulse on Al Jazeera
04 Jan 2008
MoH - MMV: Bold intervention being designed in Uganda to deliver subsidized effective antimalarials
01 Oct 2007
DHA Piperaquine wins Good Clinical Practice Journal (GCPj) Award
06 Sep 2007
US NIH grants MMV over USD 5 mn for malaria research
06 Sep 2007
Start of Phase II trial of intravenous artesunate for children with severe malaria
29 Aug 2007
Orphan Drug Status for MMV Drug DHA-Piperaquine
25 Jul 2007
World Bank Reviews MMV’s Growth and Progress
18 Jul 2007
MMV Project of the Year goes to Next Generation OZ
14 May 2007
New malaria clinical trial site inaugurated at Bagamoyo, Tanzania
10 May 2007
Dr Chris Hentschel interviewed in Kampala by AllAfrica.org
09 May 2007
Uganda and MMV explore innovative ways to give patients access to life-saving antimalarials
09 May 2007
Africa Malaria Day - A Malaria Community Statement
25 Apr 2007
Partnerships hold the key
25 Apr 2007
DNDi launches a fixed-dose ACT
02 Mar 2007
Work of MMV highlighted at World Economic Forum Annual Meeting
31 Jan 2007
Pivotal clinical trials launched for new artemisinin-based malaria drug combination
25 Jan 2007
Malaria Map: New Tool for Malaria Control
06 Dec 2006
Dutch government pledges nearly €7 million to MMV
03 Nov 2006
Medicines for Malaria Venture, Higher Colleges of Technology and Global Medical Forum Foundation Collaborate on Innovative Abu Dhabi Bio City Research Initiative to Tackle Malaria
18 Oct 2006
MMV announces a commitment of US$50 million to advance malaria research at President Clinton’s Global Initiative
21 Sep 2006
Pivotal Studies Begin for CDA in sub-Saharan Africa
25 Jul 2006
Project to jump-start efficacy of Artemisia Annua
22 Jun 2006
MMV calls for action against counterfeit drugs
06 Jun 2006
Novartis spearheads innovative malaria research project in newly created public-private partnership
23 May 2006
Irish Aid announces a grant to MMV of €9 million over the next three years
11 May 2006
MMV Stakeholders’ Meeting - Shin Poong Pharm. wins Project of the Year
06 May 2006
New Alliance to Build African Capacity for Malaria Drug and Vaccine Research
24 Apr 2006
MMV applauds WHO’s call to halt malaria monotherapy
23 Jan 2006
University of Mississippi, MMV, and DNDi to collaborate on development of anti-parasitic drugs
14 Dec 2005
RBx11160 demonstrates significant parasite reduction in patients
13 Dec 2005
MMV swims 10 km in World Swim for Malaria
03 Dec 2005
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »